JPRN-UMIN000016532已完成未知
sublingual immunotherapy for Japanese cedar pollinosis - SLIT for JCP
Bureau of social welfare and public health, Tokyo Metropolitan Goverment0 个研究点目标入组 200 人开始时间: 2015年2月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1,People that have merged with other nose disease 2,People who are using the drug for allergic disease 3,People who have oral steroid 4,People with a history of asthma 5,People who are pregnant 6,People who are breast-feeding 7,People who have serious complications 8,People who doctor has determined unsuitable
研究者
相似试验
已完成
不适用
sublingual immunotherapy for Japanese cedar pollinosis: multicenter trialJPRN-UMIN000003950ippon Medical School200
已完成
不适用
Sublingual immunotherapy using imported birch pollen extract for injectiooral allergy syndrome (OAS)JPRN-UMIN000024376Kanagawa Children's Medical Center Department of Allergy1
已完成
不适用
Sublingual immunotherapy (SLIT) with grass pollen allergen for grass pollen induced rhinoconjunctivitis in childreConjunctivitisEye DiseasesRhinoconjunctivitis, Grass pollen allergyISRCTN89345534Artu Biologicals Europe B.V. (Netherlands)204
尚未招募
不适用
Efficacy of treatments for Japanese cedar pollinosis based on guideline -combined treatment ofleukotriene receptor antagonist with H1 receptor antagonistsJapanese cedar pollinosisJPRN-UMIN000009647Okayama University100
进行中（未招募）
1 期
Grass Pollen Immunotherapy plus Dupilumab for Tolerance Induction.EUCTR2018-003456-20-GBDivision of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Disease108